Abstract: The antimicrobial properties of one of the most important secondary metabolites, Eugenol(EU), inspired us to design and synthesize three different series of derivatives enhancing its parent compound’s anti-Helicobacter pylori activity. Thus, we prepared semisynthetic derivatives through (A) diazo aryl functionalization, (B) derivatization of the hydroxy group of EU, and (C) elongation of the allyl radical by incorporating a chalcogen atom. The antibacterial evaluation was performed on the reference NCTC 11637 strain and on three drug-resistant clinical isolates and the minimal inhibitory and bactericidal concentrations (MICs and MBCs) highlight the role of chalcogens in enhancing the antimicrobial activity (less than 4 microg/mL for some compounds) of the EU scaffold (32–64 microg/mL).

Nature-Inspired Compounds: Synthesis and Antibacterial Susceptibility Testing of Eugenol Derivatives against H. pylori Strains / S. Carradori, A. Ammazzalorso, S. Niccolai, D. Tanini, I. D’Agostino, F. Melfi, A. Capperucci, R. Grande, F. Sisto. - In: PHARMACEUTICALS. - ISSN 1424-8247. - 16:9(2023), pp. 1317.1-1317.19. [10.3390/ph16091317]

Nature-Inspired Compounds: Synthesis and Antibacterial Susceptibility Testing of Eugenol Derivatives against H. pylori Strains

F. Sisto
Ultimo
2023

Abstract

Abstract: The antimicrobial properties of one of the most important secondary metabolites, Eugenol(EU), inspired us to design and synthesize three different series of derivatives enhancing its parent compound’s anti-Helicobacter pylori activity. Thus, we prepared semisynthetic derivatives through (A) diazo aryl functionalization, (B) derivatization of the hydroxy group of EU, and (C) elongation of the allyl radical by incorporating a chalcogen atom. The antibacterial evaluation was performed on the reference NCTC 11637 strain and on three drug-resistant clinical isolates and the minimal inhibitory and bactericidal concentrations (MICs and MBCs) highlight the role of chalcogens in enhancing the antimicrobial activity (less than 4 microg/mL for some compounds) of the EU scaffold (32–64 microg/mL).
eugenol; Helicobacter pylori; ; semisynthesis; chalcogens; MIC; MBC
Settore MED/07 - Microbiologia e Microbiologia Clinica
2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
Sisto 2023.pdf

accesso aperto

Descrizione: Article
Tipologia: Publisher's version/PDF
Dimensione 6.09 MB
Formato Adobe PDF
6.09 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1002908
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact